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Emerging fungal pathogens cause an expanding burden of disease across the
animal kingdom, including a rise in morbidity and mortality in humans. Yet,
we currently have only a limited repertoire of available therapeutic interven-
tions. A greater understanding of the mechanisms of fungal virulence and of
the emergence of hypervirulence within species is therefore needed for new
treatments and mitigation efforts. For example, over the past decade, an unu-
sual lineage of Cryptococcus gattii, which was first detected on Vancouver
Island, has spread to the Canadianmainland and the Pacific Northwest infect-
ing otherwise healthy individuals. The molecular changes that led to the
development of this hypervirulent cryptococcal lineage remain unclear.
To explore this, we traced the history of similar microevolutionary events
that can lead to changes in host range and pathogenicity. Here, we detail
fine-resolution mapping of genetic differences between two highly related
Cryptococcus gattii VGIIc isolates that differ in their virulence traits (phago-
cytosis, vomocytosis, macrophage death, mitochondrial tubularization and
intracellular proliferation). We identified a small number of single site variants
within coding regions that potentially contribute to variations in virulence.
We then extended our methods across multiple lineages of C. gattii to study
how selection is acting on key virulence genes within different lineages.
This article is part of the themed issue ‘Tackling emerging fungal threats
to animal health, food security and ecosystem resilience’.1. Introduction
Emerging fungal pathogens and fungal-like organisms are increasingly
threatening natural populations of animals and plants [1]. For example, the
recently discovered chytrid fungus Batrachochytrium salamandrivoranswas impli-
cated in the near extirpation of fire salamanders in 2013 in the Netherlands [2].
Race Ug99 of the basidiomycetous fungus Puccinia graminis f. sp. tritici first
detected in 1998 is now recognized as a major threat to wheat production
and food security worldwide [3], and the basidiomycetous fungus Cryptococcus
gattii (C. gattii) has expanded its range into non-endemic environments with a
consequential increase in fatal meningitis in humans [4,5]. The global threat of
these and other related diseases is underpinned by fungi harbouring complex
and dynamic genomes [6]. This leads to an ability to rapidly evolve in order
to overcome host defences [7], presenting a pressing challenge to understand
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determinants that underlie pathogenicity.
Cryptococcus gattii causes pneumonia and meningoence-
phalitis in humans following an inhalation of infectious yeast
or airborne hyphae [8]. While its sister species Cryptococcus
neoformans is most prevalent in HIV-infected individuals and
patients with other immunodeficiencies, C. gattii predomi-
nantly (although not exclusively; [9]) cause disease in healthy
people [10]. C. gattii accounts for less than 1% of all cryptococ-
cosis cases and until the late 1990swas foundmostly in tropical
and subtropical parts of the world. However, in 1999, an
outbreak ofC. gattiiwas reported on Vancouver Island in dom-
estic pets, wild animals and people [4,11]. This outbreak spread
to mainland Canada and then into the Northwestern states of
the USA and remains a major public health concern.
Cryptococcus gattii is divided into four distinct lineages (VGI,
VGII,VGIII andVGIV),with such considerable geneticvariation
that they were recently described as separate species (C. gattii,
C. deuterogattii, C. bacillisporus and C. tetragattii, respectively
[12]). VGI and VGII isolates are responsible for the majority of
infections in immunocompetent individuals in thePacificNorth-
west, the North of Australia and in Central Papua New Guinea
[13]. Although the original outbreak on Vancouver Island was
caused by at least two clonal subgroups of VGII named VGIIa
(the major genotype) and VGIIb (the minor genotype) [11], sev-
eral associated outbreaks have subsequently been reported, e.g.
VGIIc inOregon,USA [14]. Recent studies investigating the gen-
etic diversity of outbreak isolates by whole genome sequence
typing have identified an abundance of genetic diversity
within the VGII molecular type and evidence for both sexual
recombination and clonal expansions [15–17].
The ability of cryptococcal cells to parasitize phagocytes,
in particular macrophages, is a major pathogenesis mechan-
ism of cryptococcosis [18,19]. C. gattii is able to protect itself
from host-induced oxidative stresses, such as reactive
oxygen species (ROS), via an enlarged polysaccharide cap-
sule, which provides a physical barrier that interferes with
normal macrophage phagocytosis and clearance by the
immune system [20]. Although all four lineages are capable
of causing disease, a number of differences have been ident-
ified between sublineages, such as increased intracellular
proliferation rates (IPRs) in VGIIc isolates [5], or an enhanced
ability to parasitize host phagocytic cells by VGIIa outbreak
isolates. These processes are initiated upon engulfment by
macrophages, followed by a stress response that triggers
cryptococcal mitochondrial tubularization and rapid prolifer-
ation of the outbreak strains [19]. Another study identified
increased expression levels for laccase in the VGIIa isolate
R265 compared with non-outbreak strains; laccase controls
melanin production and provides protection from oxidative
damage imposed by the host immune response. In addition,
cryptococcal strains are able to escape phagocytes by a non-
lytic mechanism (expulsion or ‘vomocytosis’ [21,22]) or to
undergo ‘lateral transfer’ between phagocytes. These pro-
cesses may provide greater resistance to stresses in the
phagosome and may also have a role in the dissemination
of the pathogen from the lungs to the central nervous system.
Genomic comparisons between lineages have identified a
range of genetic differences that may contribute to differences
in fitness, ranging from chromosome copy number variation
to genomic rearrangements [23,24]. Furthermore, as many as
700 genes are unique to one or more of the four lineages,
including heat-shock proteins and iron transporters, whichcould contribute to differences in disease progression and
outcome [24]. Positive selection has also been identified
among orthologous multi-drug transporters in different
lineages and clonal groups [24]. However, new emerging or
hypervirulent genotypes arise at the population level, and
may not be detected from comparisons between more
anciently diverged isolates. Here, we combine phenotypic
typing from 20 C. gattii strains from each of the four lineages,
with a case-study genomic comparison for two highly geneti-
cally similar isolates belonging to VGIIc (EJB18 and EJB52)
that have marked differences in intracellular proliferative
rates (IPRs) and mitochondrial tubularization rates. Our
approach identifies 33 candidate nuclear genes that may con-
tribute to these hypervirulent traits. Finally, we extend our
approach to study the wider population structure and vari-
ation among a panel of 64 C. gattii isolates and demonstrate
how the methods we detail here are applicable to investi-
gating the genetic determinants that underpin virulence
across a wide range of emerging fungal pathogens.2. Results
(a) Whole genome sequencing and phenotypic typing
suggest a loss/gain pattern of hypervirulence traits
among VGIIc
Detecting microevolutionary changes requires precision
variant-calling to distinguish subtle differences with sequen-
cing or alignment error. Using a highly stringent SNP-calling
protocol (see §4b), we were able to reduce false-positive SNPs
to 4.5 per one million bases (n ¼ 77; 0.13% of all SNPs called),
while maintaining 99.3% true-positive SNPs (the remaining
0.7%were false-negatives).Applying theseparameters to 64 iso-
lates of C. gattii (table 1 and electronic supplementary material,
table S1), we identified SNPs in all isolates and used these to
construct a phylogenetic tree, illustrating the sublineages
within each of the four major lineages of C. gattii (figure 1).
Macrophage parasitism and the ability to proliferatewithin
these phagocytic effector cells are well-established virulence
traits of cryptococcal infections. To correlate genetic and
phenotypic distance, we measured a range of macrophage
interaction parameters (i.e. phagocytosis, IPR, vomocytosis,
cryptococcal mitochondrial tubularization and macrophage
death) in replicate (3X–8X) over a timecourse of macrophage
interaction (0, 18, 24 and 48 h). First, wemeasured themaximal
intracellular proliferate potential (Tmax; commonly referred to
as IPR) for 20 isolates of C. gattii including four of the six
named subclades (the outbreak clades VGIIa and VGIIc, the
recently described VGIIx [24], and VGIIb; figure 1 and
electronic supplementary material, table S2). These strains
were selected, according to previous literature and strain
detail knowledge, to represent a balanced collection of strains
(i) from the North Pacific C. gattii outbreak, (ii) from environ-
mental origin, and (iii) representing the different molecular
groups. IPR values ranged from 0.74 to 2.30, andK-means clus-
tering revealed two groups. One group contained isolates with
lower values found across all of the lineages and therefore not
correlated with phylogeny (all less than 1.5 IPR). These
included one VGI isolate, five of the seven non-clonal
subclades of VGII, both VGIIIb isolates and one VGIV isolate.
In contrast, all six of the VGIIa isolates and the VGIIx isolate
were in the cluster with higher values (greater than 1.7 IPR).
Table 1. Cryptococcus gattii strains included in this study.
strain type strain origin est. lat. est. long. source mating type
VGI B7488 USA, Oregon 43.8 2120.5 clinical alpha
VGI E566 South Australia 225.5 134.0 eucalyptus tree a
VGI EJB2 USA North Carolina, with a history
throughout the San Francisco, CA
46.0 2121.0 clinical alpha
VGI NT-10 Australia 225.5 134.0 clinical alpha
VGI Ru294 South Africa 231.0 23.7 unknown tree alpha
VGI WM179 Sydney, Australia, 1993 233.9 151.1 clinical alpha
VGI WM276 Australia 225.5 134.0 environmental alpha
VGII 2001/935 Senegal 14.2 214.4 clinical alpha
VGII 99/473 Caribbean Islands 20.8 277.6 clinical alpha
VGII CBS10089 Greece 39.5 21.8 clinical alpha
VGII CBS1930 Aruba, Caribbean Sea 12.5 270.0 goat a
VGII CBS8684 Uruguay 232.9 256.0 environmental (wasp nest) alpha
VGII ICB180 Sao Paulo, Brazil 29.5 255.8 environmental
(eucalyptus tree)
alpha
VGII ICB184 Piaui, Brazil 29.5 255.8 environmental (tree) alpha
VGII LA362 Brazil, Jaboticabal 221.3 248.3 animal (Parrot lier?) alpha
VGII LMM265 Brazil 29.5 255.8 clinical alpha
VGII MMRL2647 Caribbean Islands 225.5 134.0 clinical alpha
VGIIa B7395 USA, Washington 38.9 277.0 dog alpha
VGIIa B7422 USA, Oregon 43.8 2120.5 cat alpha
VGIIa B7467 USA, Washington 38.9 277.0 porpoise alpha
VGIIa B8577 Canada, British Columbia 53.9 2127.6 environmental alpha
VGIIa B8849 USA, Oregon 43.8 2120.5 environmental alpha
VGIIa CA1014 USA 46.0 2121.0 clinical alpha
VGIIa CBS10485 Canada, Vancouver Island 49.7 2125.2 clinical (Danish tourist) alpha
VGIIa CDCF2932 Canada, British Columbia, Kelowna 49.9 2119.5 clinical
(immunocompetent
patient)
alpha
VGIIa CDCF3016 Canada, shores island close to
Vancouver Island
49.7 2125.2 animal (dead wild dall’s
porpoise)
alpha
VGIIa CDCR271 Canada, British Columbia, Nanoose
Bay
49.3 2124.2 clinical
(immunocompetent
male)
alpha
VGIIa ENV152 Canada, Vancouver Island, Provincial
Park, Rathrevor Beach
49.3 2124.3 environmental (alder tree) alpha
VGIIa R265 Canada, British Columbia, Duncan 48.8 2123.7 clinical alpha
VGIIb B7394 USA, Washington 38.9 277.0 cat alpha
VGIIb B7735 USA, Oregon 43.8 2120.5 clinical alpha
VGIIb B8554 USA, Oregon 43.8 2120.5 dog alpha
VGIIb B8828 USA, Washington 38.9 277.0 porpoise alpha
VGIIb Ram5 Australia 225.5 134.0 clinical alpha
VGIIc B6863 USA, Oregon 43.8 2120.5 clinical alpha
VGIIc B7390 USA, Idaho 44.2 2114.8 clinical alpha
VGIIc B7432 USA, Oregon 43.8 2120.5 clinical alpha
VGIIc B7466 USA, Oregon 43.8 2120.5 cat alpha
(Continued.)
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Table 1. (Continued.)
strain type strain origin est. lat. est. long. source mating type
VGIIc B7737 USA, Oregon 43.8 2120.5 clinical alpha
VGIIc B8571 USA, Washington 38.9 277.0 clinical alpha
VGIIc B8838 USA, Washington 38.9 277.0 clinical alpha
VGIIc B8843 USA, Oregon 43.8 2120.5 clinical alpha
VGIIc EJB18 USA, Oregon 43.8 2120.5 clinical alpha
VGIIc EJB52 USA, Oregon 43.8 2120.5 clinical alpha
VGIIIa 78-1-S3A Los Angeles, California, USA, 2011 34.0 2118.3 environmental alpha
VGIIIa 97/433 Mexico 23.4 2101.7 clinical alpha
VGIIIa B8212 USA, Oregon 43.8 2120.5 unknown alpha
VGIIIa BHPP3-S1A Los Angeles, California, USA, 2012 34.0 2118.3 environmental, soil alpha
VGIIIa CA1053 California, USA 36.5 2119.7 clinical alpha
VGIIIb CA1280 USA 46.0 2121.0 clinical alpha
VGIIIa CA1308 California, USA 36.5 2119.7 clinical alpha
VGIIIb CA1508 California, USA 36.5 2119.7 clinical a
VGIIIa CA1873 USA 46.0 2121.0 clinical a
VGIIIa MCP-1A Los Angeles, California, USA, 2011 34.0 2118.3 environmental alpha
VGIIIb MCPR1-S1B Los Angeles, California, USA, 2012 34.0 2118.3 environmental, soil a
VGIIIb NIH312 California, USA 36.5 2119.7 clinical alpha
VGIIIb  VGIIx Progeny5 n.a. n.a. n.a. n.a. alpha
VGIIIa WM11_139 USA, 2011 43.8 2120.5 veterinary a
VGIIx CBS10090_Bir Greece 39.5 21.8 clinical a
VGIIx CBS10090_Bro Greece 39.5 21.8 clinical a
VGIIx LA55 NE region of Piaui, Brazil 29.5 255.8 clinical a
VGIV CBS10101 South Africa 231.0 23.7 king cheetah alpha
VGIV IND107 India 22.4 78.9 clinical alpha
VGIV WM779 South Africa, 1994 231.0 23.7 veterinary alpha
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actions via the induction of mitochondrial tubularization
(specifically, an average per cent of yeast with tubular
mitochondria), which is associated with response to, and
protection from, ROS upon engulfment [25]. Again, values
were highly variable among the four lineages (electronic
supplementary material, table S2), with the highest proportion
of tubularizing mitochondria among the subclades of VGII.
Intracellular proliferative capacity correlated significantly with
mitochondrial tubularization and yeast uptake bymacrophages
(p, 0.0001 and p ¼ 0.004, respectively, figure 1) [25]. Of
note, two VGIIc isolates show large differences in mito-
chondrial tubularization (EJB52¼ 18% and EJB18 ¼ 44%) and
IPR (EJB52¼ 1.36+0.33 IPR and EJB18 ¼ 1.71+0.35 IPR),
suggesting that these isolates are suitable for further investi-
gation. Substantial variation was also observed in the fraction
of yeast phagocytized, with uptake per cent varying from
0.5% to 31.5% (figure 1 and electronic supplementary material,
table S2). The greatest per cent uptakes were from most of
VGIIa, VGIIx and importantly VGIIc EJB52 (28.4%), whereas
VGIIc EJB18 was phagocytized less (15.7%).
We also assayed each isolate for the rate of expulsion after
phagocytosis bymacrophages (‘vomocytosis’) andmacrophage
cell death. In contrast to IPR, mitochondrial tubularization andpercentage phagocytosis, there was far lower intralineage vari-
ation in non-lytic escape (‘vomocytosis’) and in host cell death
(figure 1 and electronic supplementary material, table S2). Fur-
thermore, neither of these two phenotypicmarkers significantly
correlated (p ¼ 0.837 and p ¼ 0.235, respectively) with IPR rate.
This may be an indication that C. gattii hypervirulence is driven
by the correlated phenotypes and not by ‘vomocytosis’ or
macrophage death.
Comparing closely related isolates for shifts in pheno-
types (the pattern of IPR, mitochondrial tubularization and
phagocytosis) shows the greatest discrepancy between the
two VGIIc isolates EJB52 and EJB18. A two-tailed t-test of
the IPR replicates also suggested a difference in values
( p-value ¼ 0.0458). The limited genetic variation and large
phenotypic difference between these two isolates suggested
they were good candidates to identify the genetic differences
that may be responsible.
To determine if phenotypic variation in VGIIc stemmed
from gene loss, we measured read coverage and depth
across each gene. Read depth revealed a total of 686 pres-
ence/absence (P/A) polymorphisms in at least one isolate,
of which 16 were absent in both VGIIc isolates (electronic
supplementary material, table S3). No P/A polymorphisms
were found in VGIIa isolates to which the reference R265
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Figure 1. Correlation of phylogenetic and phenotypic data. Phenotypic data were superimposed onto the phylogenetic reconstruction of the nuclear genome and
the data clustered into high- and low-value groups using a k-means clustering approach. The abilities to proliferate within macrophages and to form tubular
mitochondria upon engulfment are strong virulence markers. (Top left) Mitochondrial tubularization and yeast uptake by macrophages were correlated ( p ,
0.0001 and p ¼ 0.004, respectively) with their intracellular proliferative rate (IPR). Asterisks indicate 100% bootstrap support from 1000 replicates, and a box
is used to highlight the VGIIc isolates that have shifts in phenotype.
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could not explain the phenotypic differences between the
two VGIIc isolates, they may be relevant to phenotypic differ-
ences between subclades (such as between VGIIa and VGIIc).
Three of the VGIIa genes absent in VGIIc have both
zinc-binding dehydrogenase and alcohol dehydrogenase
GroES-like PFAM domains. These are likely the most abun-
dant zinc-binding proteins in the cell, and may play a roleduring zinc-deprivation conditions such as within a phago-
some [26]. Two additional proteins had major facilitator
superfamily and sugar transport PFAM domains, which
may play out as differences in the ability to transport toxins
or xenobiotics out of the cell, or transport sugars into the
cell, respectively.
We classified every base of the 17.3 Mb genomes of EJB18
and EJB52, placing 98.65% into a non-ambiguous subcategory
gene ID EJB52 EJB18 annotation PFAM domains
CNBG_0001 SNP (non-synonymous) reference hypothetical protein late exocytosis, associated with golgi transport; phosphate metabolism
CNBG_0232 insertion (non-frameshift) reference hypothetical protein SUZ domain
CNBG_0580 SNP (non-synonymous) reference Nup155 Nup133; non-repetitive/WGA-negative nucleoporin
CNBG_1027 reference SNP (non-synonymous) cerevisin subtilase family; peptidase inhibitor I9
CNBG_1088 insertion (frameshift) reference ligase n.a.
CNBG_ 1192 deletion (non-frameshift) reference hypothetical protein SNF5/SMARCB1/INI1
CNBG_1482 insertion (non-frameshift) reference hypothetical protein n.a.
CNBG_1665 deletion (non-frameshift) reference HSE1 n.a.
CNBG_1847 deletion (frameshift) insertion (frameshift) histone deacetylase RPD3 histone deacetylase domain
CNBG_2344 reference SNP (non-synonymous) Sterol 3β-glucosyltransferase UDP-glucoronosyl and UDP-glucosyl transferase (GTF); GTF 28
CNBG_2480 reference SNP (non-synonymous) efflux protein EncT major facilitator superfamily
CNBG_2491 deletion (non-frameshift) reference hypothetical protein Arrestin (or S-antigen), C-terminal domain
CNBG_2491 reference insertion (non-frameshift) hypothetical protein Arrestin (or S-antigen), C-terminal domain
CNBG_2628 reference deletion (non-frameshift) hypothetical protein n.a.
CNBG_2696 insertion (non-frameshift) reference chaperone SRP40, C-terminal domain; LisH
CNBG_2828 reference SNP (non-synonymous) PEPCK phosphoenolpyruvate carboxykinase
CNBG_3379 reference SNP (synonymous) α-1, 6-mannosyltransferase Alg9-like mannosyltransferase family
CNBG_3803 SNP (non-synonymous) reference hypothetical protein n.a.
CNBG_3873 SNP (synonymous) reference histone deacetylase 6/10 histone deacetylase domain; Arb2 domain
CNBG_3995 SNP (non-synonymous) reference carboxypeptidase A4 zinc carboxypeptidase
CNBG_4063 insertion (non-frameshift) reference hypothetical protein n.a.
CNBG_4812 SNP (synonymous) reference ADP, ATP carrier protein mitochondrial carrier protein
CNBG_5309 deletion (non-frameshift) dif. del. (non-frameshift) cytoplasmic protein PSP1 C-terminal conserved region
CNBG_5312 reference SNP (non-synonymous) glucoamylase n.a.
CNBG_5651 reference insertion (non-frameshift) hypothetical protein n.a.
CNBG_5749 SNP (non-synonymous) reference hypothetical protein WD domain, G-beta repeat domain
CNBG_5891 insertion (non-frameshift) reference hypothetical protein WD domain, G-beta repeat domain
CNBG_5891 reference deletion (non-frameshift) hypothetical protein WD domain, G-beta repeat domain
CNBG_6031 SNP (non-synonymous) reference hypothetical protein 2¢-5¢ RNA  ligase superfamily; cyclic phosphodiesterase-like
CNBG_6184 insertion (non-frameshift) reference hypothetical protein n.a.
CNBG_6204 insertion (non-frameshift) reference hypothetical protein n.a.
CNBG_9229 SNP (non-synonymous) reference hypothetical protein RhoGEF domain; variant SH3 domain x2; SH3 domain; WH2 motif 
CNBG_9578 reference deletion (non-frameshift) hypothetical protein n.a.
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Figure 2. Genetic changes that underlie the increased hypervirulence of C. gattii outbreak strains were identified by comparing EJB52 (low per cent mitochondrial
tubularization and IPR) and EJB18 (high tubularization and IPR). (a) Summary of all genetic differences between EJB52 and EJB18. Single base changes are shown in
blue (b) Distance of intergenic variants between EJB52 and EJB18 to any upstream genes. (c) Thirty-one genes with genetic differences were uniquely identified
between EJB52 and EJB18. Genes are numerically ordered by their locus ID, and single base changes are highlighted. (Online version in colour.)
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poorly supported base call in one or both of the two isolates).
Nucleotide subcategories were annotated in a codon-by-codon
manner, as either fixed or transitional between the two isolates.
Only 153 differences (8.9 per Mb; figure 2a and electronic sup-
plementary material, table S4) were identified between these
isolates (compared with 60 thousand; 3.5 per kb from their
initial alignments to the VGIIa R265 reference genome; elec-
tronic supplementary material, table S1). Importantly, no
differences were detected within the mitochondrial genome,
suggesting that the phenotypic differences in the regulation
of mitochondrial tubularization are encoded in the nuclear
genome. Furthermore, no aneuploidy was detected based on
depth of coverage plots.
Of the 153 sites differing between EJB18 and EJB52, a
subset of 33 variants overlapped sites among the 6456
predicted genes of R265, including 15 SNPs and 18 indels
(figure 2c). The remaining differences fell within introns
(n ¼ 32) and intergenic (n ¼ 88) regions, differences that
could also have an impact if they, for example, fell within apromoter or repressor region. To examine this, we identified
all intergenic differences that were upstream of a gene
(figure 2b), 13 of which were within 100 nt. The closest
upstream intergenic difference was an insertion unique to
EJB52, 12 bases upstream of the STE/STE11/SSK protein
kinase (CNBG_4621), involved in Cryptococcus mating and
virulence [27]. Separately, a solute carrier family 25 (mito-
chondrial citrate transporter) gene had two upstream
intergenic differences: an insertion 46 nt upstream unique to
EJB52 and a deletion 44 nt upstream unique to EJB18. Impro-
per uptake or conversion of citrate is known to attenuate a
range of pathogens, including Cryptococcus [28–30].
Of the 31 genes that had differences between EJB52
and EJB18 (figure 2c; two genes had two differences), two
were synonymous changes, and eight were hypothetical
proteins without any assigned functional information (GO-
terms, PFAM, TIGRFAM). The remaining 23 genes had
non-synonymous differences and functional annotation. As
mitochondrial tubularization is one of the main phenotypic
differences between the two VGIIc isolates, we predicted
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teins in C. gattiiVGII, only 548 were predicted to localize to the
mitochondria; two of these genes had genetic differences
between the two VGIIc isolates. The first gene (CNBG_5651)
has an insertion (non-frameshift/modulo 3) in EJB18 (high
value tubularization), and its specific function is unclear. Fur-
thermore, this allele is not correlated with the mitochondrial
tubularization phenotype across the isolates as the insertion
was found in 40 of 66 isolates including both high and low
mitochondrial tubularization percentages. The second gene
(CNBG_5312) has a non-synonymous change (T! C, I! V)
in glucoamylase in EJB18; this change is unique to EJB18.
Glucoamylase expression is responsible for carbohydrate
metabolism in other intracellular pathogens, such as Listeria
pneumophila within amoebae [31,32], and C. gattii is also
likely evolving for protection against this [33].
Although not predicted to localize to the mitochondria,
a gene with the mitochondrial carrier protein domain
(CNBG_4812) has a unique synonymous SNP in EJB52 (low
tubularization) compared with EJB18; this change also does
not fall within a splice donor/acceptor site. Curiously, this
SNPwas also present in six of the sevenVGI isolates sequenced,
includingWM276 that also shows low tubularization. The other
strains with this change were not measured for this phenotype,
including the six other VGI isolates and one other VGIIc isolate
(B7466). Finally, it is noteworthy that two separate histone dea-
cetylases vary between the isolates, including a synonymous
SNP unique to EJB52 in CNBG_3873 annotated as ‘6/10/
Arb2’ and a deletion in EJB52!insertion in EJB18 for
CNBG_1847 annotated as ‘RPD3’. The deletion was found in
only one other isolate: the closely related VGIIc B7466, for
which we have no phenotypic data. However, it is possible
that unique variants give rise to shared phenotypes by disrupt-
ing the same gene or gene network. For example, histone
deacetylases are involved in the morphology and virulence
of Candida albicans [34].(b) Selection in the clonal groups of Cryptococcus gattii
acts upon capsule genes, heat-shock proteins and
the STE/STE11/SSK protein kinase
To examine the impact of selection on the different C. gattii
clades, we measured dN/dS (v) values for fixed differences
across six subclades of C. gattii (2a, 2b, 2c, 2x, 3a, 3b). A total
of 859 genes have dN/dS with values greater than 1, which
can be indicative of relaxed or positive selection (figure 3).
No PFAM or GO-term from these genes was enriched (accord-
ing to two-tailed Fisher’s exact test with q-value false-discovery
rate (FDR) against the remaining gene-sets). However, two
genes of known interest were identified. The first gene
(CNBG_1370) is a 1 : 1 orthologue of C. neoformans H99 Utr2
gene (with homology to chitin transglycolase), which is poten-
tially involved in capsule biosynthesis [35]. In C. gattii, this
gene is under selection in the recently named VGIIx subclade
[24] with dN ¼ 0.0063, dS ¼ 0.0059, v ¼ 1.0792. The second
gene (CNBG_0047) is in an orthogroup with C. neoformans
H99 Cap64-like proteins Cas31 and Cas3, and under selec-
tion in VGIIb (dN ¼ 0.0028, dS ¼ 0.0023, v ¼ 1.2242). Both
Cas31 and Cas3 mutants have decreased capsule sizes in
C. neoformans, as they are involved in determining the position
and the linkage of the xylose and/or O-acetyl residues on the
mannose backbone of the capsule [35,36].The reference isolate VGIIa R265 is only separated from
other VGIIa isolates by between 39 and 184 SNPs (table S1),
of which only 12were fixed (i.e. likely errors in the R265 assem-
bly itself ). Tomeasure selection in VGIIa, we therefore used the
branch site model (BSM) of selection implemented by PAML
[37]. We found 113 genes with significant differences
(x22ð2DLnlÞ , 0:01) after Benjamini–Hochberg (BH) multiple
correction. Previously when we calculated these values for
VGIIa (subset 5 in [24]) for non-fixed differences across mul-
tiple isolates with BH correction and q-value, 0.01, without
adjusting the NS sites parameter, we identified an almost
entirely distinct list of 87 genes, apart from two genes that
were identified in both (CNBG_5460 (Fungal Zn(2)-Cys(6)
binuclear cluster domain) and CNBG_4219 (domain of
unknown function 1708)). Again, no PFAM or GO-term from
these genes was enriched (according to two-tailed Fisher’s
exact test with q-value FDR). However, we did identify a tran-
scription factor from the Zn(2)-Cys(6) family named CTA4
that is a nitric oxide-responsive element, and required for the
nitrosative stress response in C. albicans [38].
Other important genes found to be under selection in the
VGIIa branch using the BSM included a heat-shock protein
71 (CNBG_5963) and an ABC transporter (MDR/TAP)
member 1 (CNBG_9005), both of which are known to be
involved in virulence by a range of pathogens [39–42]. Selec-
tion was found in the VGIIa branch for the STE/STE11/SSK
protein kinase (CNBG_4621), which was also identified and
discussed earlier for having the closest (12 nt) upstream inter-
genic difference between VGIIc isolates EJB52 and EJB18.
Finally, an orthologue to the C. neoformans H99 capsule gene
Pmt4 (C. gattii gene CNBG_0576) was found to be under selec-
tion (x22ð2DLnlÞ ¼ 6:64 106)—specifically on a histidine at
position 264. Furthermore, C. neoformans Pmt4 mutants have
decreased capsule sizes [35]. Therefore, at least three of the
four clonal subgroups of C. gattii VGII (a, b and x) have
evidence for selection within microevolutionary timescales
in one of their capsule biosynthesis genes.3. Discussion
The aetiological agents of infectious disease impose a huge
burden on human society. By understanding their biology,
reproduction and mechanisms of infection, we are able
to assess and discover new strategies for mitigating their
impact. In recent years, fungi have gainedwidespread attention
for their ability to rapidly emerge and threaten both animal and
plant species across a global scale [1]. However, many features
of their genomes that enable them to successfully adapt to infect
diverse hosts and inhabit a wide range of ecological niches
remain cryptic [6], especially for newly evolved emerging
lineages. The underlying mechanism driving outbreaks
caused by C. gattii has been puzzling researchers for over a
decade. Compounding this is the fact that its virulence is
likely a consequence of adaptations that have evolved for pro-
tection against environmental predators such as amoebae [33]
(unless it is surviving and escaping out of dead animals).
Here, we have combined whole genome sequencing with
phenotypic analysis to identify recent genetic changes that
might underpin cryptococcal hypervirulence. Our pheno-
typic analysis demonstrated that IPR and mitochondrial
tubularization, but not phagocytosis or expulsion by the
host, correlate strongly with hypervirulence. This finding
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potential in future studies working with these phenotypes.
One possible explanation is that there is a set of general
virulence factors that allow both C. neoformans and C. gattii
to establish within the human host. However, in the
C. gattii hypervirulent strains, only the subset responsible
for IPR and mitochondrial tubularization provide enhanced
parasitism of innate immune effectors. Thus, our study
supports previous findings that indicate the importance of
IPR in cryptococcal virulence and suggests that IPR and mito-
chondrial tubularization may be useful as ‘proxy’ markers ofvirulence. We also found that these features can be surpris-
ingly variable, even within very closely related isolates of a
given subclade, such as those between EJB52 (low tubulariza-
tion and IPR) and EJB18 (high tubularization and IPR) of
VGIIc.
No differences were found between the mitochondrial
genomes of the VGIIc isolates EJB52 and EJB18, suggesting
that differences in their mitochondrial tubularization stems
from differences in their nuclear genome—which already
is thought to control mitochondrial function, fusion and fis-
sion [43]. In contrast, comparing the nuclear genomes of the
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might be involved in the differences we found in cryptococcal
hypervirulence. It is unlikely that all of these loci will be
directly involved in virulence regulation. However, one or
more of these genes are clear candidates, such as the two
genes that localize to the mitochondria, including the gluco-
amylase or the two histone deacetylases. Although the
variants were not correlative across the species at large,
there may be numerous unique genetic routes to similar
phenotypes. Some of the phenotypic differences may also be
explained by non-direct, and/or epistatic, pleiotropic or epi-
genetic means. Potentially non-direct acting variants were
identified within the intergenic regions, sometimes falling
close upstream of transcription start sites, such as the insertion
unique to EJB52 immediately upstream of the STE11/SSK
protein kinase. That this gene appears to be under selection
in the sister subclade VGIIa suggests that this is at least a
region of dynamic variation, if not potentially involved in
some phenotypic differences between these isolates.
The approach we have taken in this study is to combine
phenotypic screening with whole genome comparisons in
an attempt to identify the genomic determinants underpin-
ning fungal virulence. To reduce the impact of sequencing
errors, assembly errors in the reference sequence, alignments
errors and variant call errors, it is essential to assess false-
discovery rates and respond to those sources of error in an
iterative approach [44]. In this study, we have identified
153 high confidence genetic differences that could explain
differences in virulence traits between isolates. Detection
of microevolutionary events can ascribe new mechanisms
behind increased virulence, such as the increased expression
of FRE3-encoded iron reductase in C. neoformans passaged in
mice [45], or a single de novo heterozygous position within
a gene called SSN3 capable of restoring filamentation in a
non-filamentous C. albicans mutant [46].
The mechanisms behind changes in mitochondrial tubu-
larization and IPR, which appear to be linked, may be the
result of one or more genetic differences between high- and
low-value isolates (such as those identified here). The
number of genetic differences is sufficiently small that
hypotheses can be generated and experimentally validated
via gene disruptions or allele-swaps [47]. Alternatively,
large panels of isolates can be screened via a genome-wide
association study approach [48]. Where protein structures
have been resolved, and are available, sites of positive
selection are often in regions at the host–pathogen interface
[49], further guiding a functional prediction. Finally,
upstream variants that impact expression levels could be
characterized using RNA-Seq. Ultimately, progress in patho-
genomics heavily relies on open access and usability of
well-maintained databases of sequence data, functional
information and annotation, and pathogen-specific online
resources for community-driven efforts.
We complimented the comparison of two closely related
isolates with selection analysis across fixed variants, for
which dN/dS ratios were originally developed [50]. By focusing
only on fixed differences, we found evidence for selection in
capsule biosynthesis genes in each of the other three subclades
of VGII, each of which had been phenotyped via mutants as
having an effect on capsule size or likely to be involved in its
assembly. Selection across these genes suggests that each sub-
clade of VGII is generating new alleles and variation within
the capsule genes, some of which may result in new peaks inan adaptive landscape, and become a distinguishing genetic
feature of their clonal expansion.4. Material and methods
(a) Yeast and mammalian cells, growth conditions
and phenotypic analysis
Twenty of the 64 C. gattii strains (table 1; SRP017762) typed in
this study were cultured in liquid or agar YPD media (1% pep-
tone, 1% yeast extract, 2% D-(þ)-glucose) for 24 h at 258C
rotating at 20 rpm [13,14,19,25,51] prior to experiments. Mamma-
lian J774 macrophage-like cells were grown as described
previously [13,14,19,25,51].
Macrophageswere infectedwith yeast cells and IPRmonitored
as previously described [13,14,19,25,51]. Cryptococcal mitochon-
drial morphology was determined as described previously [5].
We would like to note that some of the IPR and mitochondrial
tubularization data were previously presented (see [25]), although
this paper included additional biological repeats. For analysis of
vomocytosis and macrophage cell death of sequenced strains,
time-lapse images were captured on a TE2000 (Nikon) enclosed
in a temperature-controlled and humidified environmental
chamber (Okolabs) with 5% CO2 at 378C with Digital Sight DS-
Qi1MC camera (Nikon), 20 objective (Ph1 PLAN APO), using
NIS elements AR software (Nikon). Images were captured every
2 min for 24 h. Vomocytosis (non-lytic expulsion of intracellular
cryptococci) and infected macrophage cell death (disintegration
of macrophage containing one or more cryptococci) were scored
blind from four separate experiments for each of the 20 strains.
Clusters of phenotypes were inferred via k-means clustering in R
(kmeans) with 1000 iterations.
(b) Variant-calling and sequence analysis
Alignment and SNP-calling parameters were initially optimized.
The recently updated [24] nuclear and mitochondrial genome
sequences and feature files for C. gattii isolate VGIIa R265a
were used (GenBank project accession number AAFP01000000).
Additional isolates sequenced and described in previous studies
[16,24,52] were obtained from the short read archive (SRA) and
converted from SRA format to FASTQ using the SRATOOLKIT
v. 2.3.3–4. Illumina reads were aligned to the genome sequence
using Burrows–Wheeler aligner v. 0.7.4 mem [53] with default
parameters to obtain high depth alignments (average 116X),
and converted to pileup format using SAMTOOLS v. 0.1.18 [54].
To act as a control for sequencing, alignment and SNP-calling,
we included the reference strain R265 in our panel of isolates.
The genome analysis toolkit (GATK) [55] v. 2.7-4-g6f46d11
was used to call both variant and reference bases from the
alignments. First, the Picard tools AddOrReplaceReadGroups,
MarkDuplicates, CreateSequenceDictionary and ReorderSam
(see http://broadinstitute.github.io/picard) were used to pre-
process the alignments. We used GATK RealignerTargetCreator
and IndelRealigner for resolving misaligned reads close to
indels on parental–progeny pairs of isolates to avoid discrepan-
cies between isolates. Next, GATK UnifiedGenotyper (with
haploid genotyper ploidy setting) was run with both SNP and
INDEL genotype likelihood models (GLMs). We additionally
ran BaseRecalibrator and PrintReads for base quality score re-
calibration on those initial sites for GLM SNP and then
re-called variants with UnifiedGenotyper (emitting all sites). We
next merged and sorted all of the calls, and ran VariantFiltration
with the parameters ‘QD, 2.0, FS. 60.0, MQ, 40.0’. Next, we
removed any base that had less than a minimum genotype quality
of 50, or a minimum depth of 10. Finally, we removed any pos-
itions that were called by both GLMs (i.e. incompatible indels
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sites that did not include a PASS flag.
To assess the ability of GATK v. 2.7–4 UnifiedGenotyper to
identify variants, we realigned reads from the reference isolate
R265 back to the R265 genome after introducing 60 000 SNPs
(corresponding to within VGII variation) and calculated the
FDR [44]. Our alignment and SNP-calling approach were opti-
mized for maximum specificity, which was necessary for
characterizing microevolutionary differences. Specifically, we
identified 59 578 (99.30%) true-positive SNPs, but only found
77 (0.13%) false-positive SNPs. For gene presence/absence poly-
morphisms, we counted all genes that had less than three times
depth of coverage.
For our phylogenetic analysis, we extracted all positions that
were called single base homozygous (reference or SNP) and poly-
morphic in one or more isolate in the 66 isolates (figure 1)
encompassing 1 192 514 nuclear sites and 767 mitochondrial
sites. We inferred the phylogeny of the isolates using RAxML v.
7.7.8 with the GTRCAT model and 1000 bootstrap replicates. For
the PAML [37] selection analysis, we used the same tree building
parameters on a subset of variants that were fixed in each of the
isolates in one of six subclades, encompassing 647 792 sites.
Genes that localized to the mitochondria were identified using
TARGETP [56]. For our selection analysis, we calculated dN/dS with
yn00 of PAML [37] implementing the Yang and Nielsen method
[57] on every gene in each of the six subclades (2a, 2b, 2c, 2x, 3a,
3b) using only fixed differences. For VGIIa, we used Codeml of
PAML [37], implementing the BSM A (model ¼ 2, NSsites ¼ 2,
fix_omega ¼ 0) compared with the null model (model ¼ 2,
NSsites ¼ 3, fix_omega ¼ 1, omega ¼ 1) on every gene. Next,
we calculated a Chi-squared test with 2 degrees of freedomfor 2  the log likelihood difference between the two compared
models (x22ð2DLnlÞ) with BH multiple correction, and significance
set at q, 0.01. Seven hundred and fourteen genes had values ran-
ging from 1 to 2.25237, whereas the remaining genes did not have
values (e.g. owing to insufficient genetic distance).
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